후기발현 생식샘저하증에서 경피용 테스토스테론(Testogel？)의 투여 효과: 혈중 테스토스테론의 농도 및 AMS 설문지에 근거한 증상점수의 변화 = The Efficacy of Transdermal Testosterone(Testogel？) in Late Onset Hypogonadism Patients: Changes in Serum Testosterone Level and Symptom Scores Based on Aging Males’ Symptoms Scale

참고문헌 (Reference)

1 Morley J.E, "Validation of a screening questionnaire for androgen deficiency in aging males." 49 : 1239-1242, 2000

2 Snyder P.J, "Treatment of male hypogonadism with testosterone enanthate." 51 : 1335-1339, 1980

3 Bals-Pratsch M, "Transdermal testosterone substitution therapy for male hypogonadism." 2 : 943-946, 1986

4 Wang C, "Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men." Testosterone Gel Study Group. 85 : 2839-2853, 2000

5 Swerdloff R.S, "Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel." 6 : 207-211, 2003

6 Douglas T.H, "The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen." 79 : 789-800, 1975

7 Werner A.A, "The male climacteric: report of 273 cases." 112 : 1143-1143, 1939

8 Svetek D.A, "The effect of parenteral testosterone replacement in prostate specific antigen in hypogonadal men with erectile dysfunction." 157 : 1775-1777, 1997

9 Douglas T.H, "The effect of exogenous testosterone replacement in prostate specific antigen and prostate specific membrane antigen levels in hypogonadal men." 59 : 246-250, 1995

10 Kaufman J.M, "The effect of androgen supplementation therapy on the prostate." 6 : 166-174, 2003

11 Ebert T, "The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel." 47 : 137-146, 2005

12 Moore C, "The aging males' symptoms scale (AMS) as outcome measure for treatment of androgen deficiency." 46 : 80-87, 2004

13 Alexandersen P, "The aging male: testosterone deficiency and testosterone replacement." 173 : 157-169, 2004

14 Nieschlag E, "Testosterone replacement therapy: current trends and future directions." 10 : 409-419, 2004

15 Leichtnam M.L, "Testosterone hormone replacement therapy: state-of-the-art and emerging technologies." 9 : 1-16, 2006

16 Wu F.C, "Steroidogenesis and androgen use and abuse." 6 : 403-737, 1992

17 Heinemann L.A, "Sensitivity as outcome measure of androgen replacement: the AMS scale." 4 : 23-, 2006

18 Basaria S, "Risks versus benefits of testosterone therapy in elderly men." 15 : 131-142, 1999

19 Wang C, "Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study." 85 : 964-969, 2000

20 Handelsman D.J, "Pharmacokinetics and pharmacodynamics of testosterone pellets in man." 71 : 216-222, 1990

21 Mooradian A.D, "Management of the cardinal feature of andropause." 13 : 145-160, 2006

22 Morley J.E, "Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men." 46 : 410-413, 1997

23 Swerdloff R.S, "Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men." 85 : 4500-4510, 2000

24 Deslypere J.P, "Leydig cell function in normal men. Effect of age, life style, residence, diet and activity." 59 : 955-961, 1984

25 Vermeulen A, "Influence of some biological indices on sex hormone binding globulin and androgen levels in aging or obese males." 81 : 1821-1826, 1996

26 Marbury T, "Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel." 24 : 115-120, 2003

27 Morales A, "Clinical practice guideline for screening and monitoring male patients receiving testosterone supplementation therapy." 8 : 95-97, 1996

28 Park J.S, "Changes in the quality of life after tansdermal testosterone (Androderm) supplement therapy in the aging male." 40 : 1057-1065, 1999

29 Morales A, "Androgen replacement therapy in aging men with secondary hypogonadism." 4 : 151-162, 2001

30 Gray A, "Age, disease, and changing sex hormone in the middle-aged men: results of the Massachusetts male aging study." 73 : 1016-1025, 1991

31 Swerdloff R.S, "A review of the pharmacokinetics and biologic effects of testosterone gel and patches in hypogonadal men: application to older men with androgen deficiency." 5 : 33-53, 2002

32 Barret C.E, "A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease." 315 : 1519-1524, 1986

33 McNicholas T.A, "A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function." 91 : 69-74, 2003

34 Heinemann L.A.J, "A new ‘aging males’ symptoms'(AMS) rating scale." 2 : 105-114, 1999

35 Vermeulen A, "A critical evaluation of simple methods for the estimation of free testosterone in serum." 84 : 3666-3672, 1999